K
Keith M. Sullivan
Researcher at Duke University
Publications - 458
Citations - 40788
Keith M. Sullivan is an academic researcher from Duke University. The author has contributed to research in topics: Transplantation & Total body irradiation. The author has an hindex of 105, co-authored 447 publications receiving 39067 citations. Previous affiliations of Keith M. Sullivan include American Cancer Society & Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.
Dinesh Khanna,Celia J. F. Lin,Daniel E. Furst,Jonathan G. Goldin,Grace Kim,Masataka Kuwana,Yannick Allanore,Marco Matucci-Cerinic,Oliver Distler,Yoshihito Shima,Jacob M van Laar,Helen Spotswood,Bridget Wagner,Jeffrey Siegel,Angelika Jahreis,Christopher P. Denton,Eleonora Lucero,Bernardo A. Pons-Estel,Mariano Rivero,Guillermo Tate,Vanessa Smith,Ellen De Langhe,Rasho Rashkov,Anastas Batalov,Ivan Goranov,Rumen Stoilov,James V. Dunne,Sindhu R. Johnson,Janet E. Pope,Dušanka Martinović Kaliterna,Mette Mogensen,Anne Braae Olesen,Joerg Henes,Ulf Müller-Ladner,Gabriela Riemekasten,Alla Skapenko,Panayiotis G. Vlachoyiannopoulos,Emese Kiss,Tünde Minier,Lorenzo Beretta,Elisa Gremese,Gabriele Valentini,Yoshihide Asano,Tatsuya Atsumi,Hironobu Ihn,Tomonori Ishii,Osamu Ishikawa,Hiroki Takahashi,Kazuhiko Takehara,Yoshiya Tanaka,Yoshioki Yamasaki,Loreta Bukauskiene,Irena Butrimiene,Gabriel Medrano Ramirez,Cesar Ramos-Remus,Tatiana Sofia Rodriguez Reyna,Jeska K de Vries-Bouwstra,Bogdan Batko,Sławomir Jeka,Eugeniusz J. Kucharz,Maria Majdan,Marzena Olesińska,Zaneta Smolenska,Jose Alves,Maria José Santos,C. Mihai,Simona Rednic,Ivan Castellvi Barranco,Francisco Javier Lopez Longo,Carmen Simeon Aznar,Patricia Carreira,Ulrich A. Walker,Emma Derrett-Smith,Bridget Griffiths,Neil McKay,Jacob Aelion,Michael S. Borofsky,Roy Fleischmann,Joseph Z. Forstot,Suzanne Kafaja,M. Faisal Khan,Michael D. Kohen,Richard J. Martin,Fabian Mendoza-Ballesteros,Alireza Nami,Shirley Pang,Grissel Rios,Robert W. Simms,Keith M. Sullivan,Virginia D. Steen +89 more
TL;DR: Findings for the secondary endpoint of FVC% predicted indicate that tocilizumab might preserve lung function in people with early SSc-ILD and elevated acute-phase reactants.
Journal Article
Chronic cutaneous graft-versus-host disease in man.
Howard M. Shulman,George E. Sale,K. G. Lerner,E. A. Barker,Paul L. Weiden,Keith M. Sullivan,B B Gallucci,Thomas Ed,R Storb +8 more
TL;DR: This clinicopathologic study of patients with chronic graft-versus-host disease (GVHD) after allogeneic marrow transplantation emphasizes the most prominent feature of the syndrome, the cutaneous aspects, and describes the ophthalmic-oral sicca syndrome with sialoadenitis and the neurologic findings.
Journal ArticleDOI
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.
Michael Binks,Jakob Passweg,D. Furst,P. Mcsweeney,Keith M. Sullivan,C. Besenthal,J. Finke,H. H. Peter,J.M. van Laar,Ferdinand C. Breedveld,W. E. Fibbe,D. Farge,E. Gluckman,Franco Locatelli,Alberto Martini,F.H.J. van den Hoogen,L. B. A. Van De Putte,A. V. Schattenberg,R. Arnold,P. A. Bacon,P. Emery,Ildefonso Espigado,B. Hertenstein,Falk Hiepe,A. Kashyap,I. Kotter,A. Marmont,A. Martinez,María Jesús Pascual,Alois Gratwohl,H. G. Prentice,C. Black,A Tyndall +32 more
TL;DR: Despite a higher procedure related mortality rate from HSCT in SSc compared with patients with breast cancer and non-Hodgkin's lymphoma, the marked impact on skin score, a surrogate marker of mortality, the trend towards stabilisation of lung involvement, and lack of other treatment alternatives justify further carefully designed studies.
Journal ArticleDOI
Intestinal and Hepatic Complications of Human Bone Marrow Transplantation. Part II
George B. McDonald,George B. McDonald,Howard M. Shulman,Howard M. Shulman,Keith M. Sullivan,Keith M. Sullivan,Gerald D. Spencer,Gerald D. Spencer +7 more
TL;DR: The authors thank E. Donnall Thomas for his constant encouragement; Derek Jewell for his gift of time; Kathleen McDonald for her editing skills; and Barbara Hicks, Patricia Jenkins, and Maxine Cormier for their help in typing the manuscript.
Journal ArticleDOI
Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease.
Keith M. Sullivan,Robert P. Witherspoon,Rainer Storb,H. J. Deeg,S Dahlberg,Jean E. Sanders,FR Appelbaum,Kristine Doney,Paul L. Weiden,Claudio Anasetti +9 more
TL;DR: Alternating-day cyclosporine and prednisone has acceptable toxicity and appears to improve survival in patients with high-risk chronic GVHD.